OncoSec Medical Inc is a biotechnology company focused on designing, developing and commercializing gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer.
Our STA Research today shows that the stock is due for a 94% increase in it’s stock valuation within a 6 to 12 month duration.  Yahoo Finance Analyst Report indicates a 142% increase. Our STA Research rating indicates the stock a Strong Buy with Bearish near term sentiment.
